Stay updated on Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial
Sign up to get notified when there's something new on the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page.

Latest updates to the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA site-wide notice about NIH terminology appears above the 403 error page, and the footer revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check28 days agoChange DetectedThe site footer revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check42 days agoChange DetectedAn error page displaying 403 Forbidden now appears in place of the study record, replacing the typical study details with a basic header and navigation. Core study information (protocol details, sponsor/investigator info, locations, and outcome measures) is no longer accessible on the page.SummaryDifference18%

- Check49 days agoChange DetectedUI label updated from 'Find Contact Information' to 'Find contact information'. The page now shows Revision: v3.7.0, replacing the previous v3.6.6.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 at the bottom of the page, indicating a new page version. This reflects a minor maintenance update to the page’s version history rather than substantive changes to study details.SummaryDifference0.1%

Stay in the know with updates to Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page.